Hirohata Shunsei, Yanagida Tamiko, Nampei Akihide, Kunugiza Yasuo, Hashimoto Hideo, Tomita Tetsuya, Yoshikawa Hideki, Ochi Takahiro
Teikyo University School of Medicine, Tokyo, Japan.
Arthritis Rheum. 2004 Dec;50(12):3888-96. doi: 10.1002/art.20729.
To examine the capacity of bone marrow CD34+ cells to generate endothelial cells, in order to assess the role of bone marrow in neovascularization in the synovium of rheumatoid arthritis (RA).
CD34+ cells purified from the bone marrow of 13 patients with active RA and 9 control subjects (7 osteoarthritis [OA] patients and 2 healthy individuals) were cultured in the presence of stem cell factor (10 ng/ml) and granulocyte-macrophage colony-stimulating factor (1 ng/ml). After 18 days of incubation, the generation of endothelial cells was assessed by flow cytometry. The generation of endothelial cells was compared with the degree of vascularization in the synovial tissues and with the microvessel densities in the synovium, as determined by microscopy. The expression of vascular endothelial growth factor receptor 2/kinase insert domain receptor (KDR) messenger RNA (mRNA) in CD34+ cells was examined by quantitative reverse transcription-polymerase chain reaction.
The generation of CD14+ cells from bone marrow-derived CD34+ cells from RA patients was comparable to that from control subjects. However, the generation of von Willebrand factor (vWF)-positive cells and CD31+/vWF+ cells from RA bone marrow-derived CD34+ cells was significantly higher than that from control subjects (P = 0.004 and P = 0.030, respectively). The generation of vWF+ cells from bone marrow CD34+ cells correlated significantly with the microvessel densities in the synovial tissues (r = 0.569, P = 0.021). Finally, RA bone marrow CD34+ cells expressed KDR mRNA at higher levels than OA bone marrow CD34+ cells.
These results indicate that RA bone marrow CD34+ cells have enhanced capacities to differentiate into endothelial cells in relation to synovial vascularization. The data therefore suggest that bone marrow CD34+ cells might contribute to synovial neovascularization by supplying endothelial precursor cells and, thus, play an important role in the pathogenesis of RA.
检测骨髓CD34+细胞生成内皮细胞的能力,以评估骨髓在类风湿关节炎(RA)滑膜新生血管形成中的作用。
从13例活动期RA患者及9例对照者(7例骨关节炎[OA]患者和2例健康个体)的骨髓中纯化出CD34+细胞,在干细胞因子(10 ng/ml)和粒细胞-巨噬细胞集落刺激因子(1 ng/ml)存在的情况下进行培养。孵育18天后,通过流式细胞术评估内皮细胞的生成情况。将内皮细胞的生成情况与滑膜组织中的血管化程度以及通过显微镜测定的滑膜微血管密度进行比较。通过定量逆转录-聚合酶链反应检测CD34+细胞中血管内皮生长因子受体2/激酶插入结构域受体(KDR)信使核糖核酸(mRNA)的表达。
RA患者骨髓来源的CD34+细胞生成CD14+细胞的情况与对照者相当。然而,RA骨髓来源的CD34+细胞生成血管性血友病因子(vWF)阳性细胞和CD31+/vWF+细胞的情况显著高于对照者(分别为P = 0.004和P = 0.030)。骨髓CD34+细胞生成vWF+细胞的情况与滑膜组织中的微血管密度显著相关(r = 0.569,P = 0.021)。最后,RA骨髓CD34+细胞表达KDR mRNA的水平高于OA骨髓CD34+细胞。
这些结果表明,与滑膜血管化相关,RA骨髓CD34+细胞分化为内皮细胞的能力增强。因此,数据提示骨髓CD34+细胞可能通过提供内皮前体细胞促进滑膜新生血管形成,从而在RA发病机制中发挥重要作用。